Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study CR9112792, a Study to Assess Bone Mineral Density Changes in Post-menopausal Osteoporotic Women Following Discontinuation of Ronacaleret or Placebo Treatment in Study CR9108963

NCT00891553 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00891553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00891553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study CR9112792, a Study to Assess Bone Mineral Density Changes in Post-menopausal Osteoporotic Women Following Discontinuation of Ronacaleret or Placebo Treatment in Study CR9108963
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
June 30, 2009
Enrollment
171 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis